当前位置:Public Access >页面
Chinese/English
Distamab Vedotin plus Anlotinib treatment in advanced non-small-cell lung cancer patients harboring HER2 variations: a single arm, prospective, exploratory clinical study
Filter Options
Patient No. Patient Name Patient Gender
Sitting Education Date of enrollment FromTo
       More Options
Patient No Gender Date of enrollment Sitting Creater Operate
NO participants recorded。